ACUTAAS
ACUTAAS · Corporate filings
NSE
Financial Charts & Report quarterly revenue, profit, margins, growth, and price overlay
Stock market charts for ACUTAAS quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns vs Sector, Nifty 50, Sensex, Nifty 500
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
NSE synced data
Corporate Governance SEBI integrated governance filing
NSE synced data
Loading governance disclosure...
Announcements
No announcements available from NSE right now.
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
No corporate actions available from NSE right now.
Board Meetings
30 Apr 2026
ACUTAAS CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 30-Apr-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend.
30 Apr 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
28 Jan 2026
ACUTAAS CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 28-Jan-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 .
28 Jan 2026
To consider and approve the financial results for the period ended December 31, 2025
17 Oct 2025
ACUTAAS CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 17-Oct-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2025 .
17 Oct 2025
To consider and approve the financial results for the period ended September 30, 2025
30 Jul 2025
ACUTAAS CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 30-Jul-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2025 .
30 Jul 2025
To consider and approve the financial results for the period ended Jun 30, 2025